X0609 4 2026-10-01 false 0001088856 CORCEPT THERAPEUTICS INC CORT 0001817838 Lyon Joseph Douglas false C/O CORCEPT THERAPEUTICS INCORPORATED 101 REDWOOD SHORES PARKWAY REDWOOD CITY CA 94065 false true false false See Remarks true Common Stock 2026-10-01 4 M false 810 13.56 A 6493 D Common Stock 2026-10-01 4 S false 810 115.3985 D 5683 D Common Stock 2026-10-02 4 M false 3357 13.56 A 9040 D Common Stock 2026-10-02 4 M false 5833 19.26 A 14873 D Common Stock 2026-10-02 4 S false 4446 115.6970 D 10427 D Common Stock 2026-10-02 4 S false 4744 116.5407 D 5683 D Stock option (right to buy) 13.56 2026-10-01 4 M false 810 0.00 D 2030-02-07 Common Stock 810 3357 D Stock option (right to buy) 13.56 2026-10-02 4 M false 3357 0.00 D 2030-02-07 Common Stock 3357 0 D Stock option (right to buy) 19.26 2026-10-02 4 M false 5833 0.00 D 2032-02-02 Common Stock 5833 44167 D Includes 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 398 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 537 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 130 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on June 10, 2026 in effect at the time of this transaction. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $115.23 to $115.615 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $115.23 to $116.21 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.25 to $116.98 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Fully exercisable. Chief Accounting & Technology Officer /s/ Joseph Douglas Lyon 2026-10-05